Company’s 36-month beta value is 1.14.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MBOT is 35.98M, and currently, short sellers hold a 18.83% ratio of that floaft. The average trading volume of MBOT on June 04, 2025 was 2.42M shares.
MBOT) stock’s latest price update
The stock price of Microbot Medical Inc (NASDAQ: MBOT) has jumped by 1.65 compared to previous close of 2.73. Despite this, the company has seen a fall of -1.94% in its stock price over the last five trading days. globenewswire.com reported 2025-04-23 that The addition of a seasoned VP of Marketing compliments the recent hiring of the Company’s VP of Sales to establish its commercialization readiness infrastructure
MBOT’s Market Performance
Microbot Medical Inc (MBOT) has experienced a -1.94% fall in stock performance for the past week, with a 11.00% rise in the past month, and a 98.21% rise in the past quarter. The volatility ratio for the week is 5.32%, and the volatility levels for the past 30 days are at 4.00% for MBOT. . The simple moving average for the past 20 days is 5.95% for MBOT’s stock, with a 82.98% simple moving average for the past 200 days.
Analysts’ Opinion of MBOT
Many brokerage firms have already submitted their reports for MBOT stocks, with H.C. Wainwright repeating the rating for MBOT by listing it as a “Buy.” The predicted price for MBOT in the upcoming period, according to H.C. Wainwright is $26 based on the research report published on January 13, 2020 of the previous year 2020.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see MBOT reach a price target of $12, previously predicting the price at $10. The rating they have provided for MBOT stocks is “Buy” according to the report published on December 24th, 2019.
Ladenburg Thalmann gave a rating of “Buy” to MBOT, setting the target price at $1.75 in the report published on January 31st of the previous year.
MBOT Trading at 22.22% from the 50-Day Moving Average
After a stumble in the market that brought MBOT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.90% of loss for the given period.
#####
#####
Stock Fundamentals for MBOT
The total capital return value is set at -0.32. Equity return is now at value -66.48, with -61.02 for asset returns.
Based on Microbot Medical Inc (MBOT), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -67.25.
Currently, EBITDA for the company is -11.35 million with net debt to EBITDA at 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 16.19.
Conclusion
In a nutshell, Microbot Medical Inc (MBOT) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
